Key facts
- SiteLabs’s last known valuation is $12.5M (Aug 2025).
- It has raised $3.0M across 1 recorded rounds; the latest was Seed Round ($2.0M) in Aug 2025.
- Notable investors include Labcorp Venture Fund, Angels Capital, SC Launch, South Carolina Research Authority, Boomerang Ventures.
- SiteLabs has filed 1 Form D with the SEC, most recently Dec 2025 ($2.0M sold to 13 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for SiteLabs
Funding rounds
1 roundsAbout SiteLabs
Operator of a technology platform designed to empower independent pharmacies as a front door for healthcare access through simple screenings and diagnostics. The company's platform offers a connected network that links independent pharmacies with health systems, health plans, and pharmaceutical companies, enabling these organizations to reach underserved people earlier, improve engagement, and support better health outcomes.
- Sector
- Healthcare
- HQ
- Anderson, SC, United States
- Founded
- 2020
- Employees
- 10
- Website
- sitelabsglobal.com/
- Ownership
- Privately Held (backing)
SiteLabs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SiteLabs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SiteLabs in its N-PORT filings yet. We sweep new filings monthly.